EC-Logo-2018_TM_CMYK.jpg
electroCore to Join Russell Microcap® Index
June 11, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its stock is on the...
EC-Logo-2018_TM_CMYK.jpg
electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
June 06, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced...
EC-Logo-2018_TM_CMYK.jpg
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
June 03, 2024 08:30 ET | electroCore, Inc.
ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces First Quarter 2024 Financial Results
May 08, 2024 16:05 ET | electroCore, Inc.
Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023Company to host a conference call and webcast today, May 8, 2024 at 4:30 PM EST ROCKAWAY, N.J., May 08,...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in Upcoming Investor Conferences
March 12, 2024 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Third Quarter 2023 Financial Results
November 08, 2023 16:01 ET | electroCore, Inc.
Record third quarter 2023 net sales of $4.5 million, an increase of approximately 128% over third quarter 2022 Company increases revenue guidance for full year 2023 to $15.0 million - $15.5...
EC-Logo-2018_TM_CMYK.jpg
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)
July 25, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer reviewed...
EC-Logo-2018_TM_CMYK.jpg
electroCore Provides Select Second Quarter 2023 Financial Guidance
July 11, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today provided select preliminary...
EC-Logo-2018_TM_CMYK.jpg
TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project
June 27, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., June 27, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its TAC-STIM non-invasive...
Think Power Solution
Think Power Solutions to Discuss How Human Performance Philosophy Helps to Create a Safe Work Culture
March 28, 2023 09:01 ET | Think Power Solutions
Plano, Texas, March 28, 2023 (GLOBE NEWSWIRE) -- Think Power Solutions, a leading tech-enabled infrastructure management solutions provider, today announced that its CEO and Director of Human...